Tue.Feb 27, 2024

article thumbnail

OTC Colon Cancer Screening Test Now Available in Pharmacies Across US

Drug Topics

Reese Pharmaceutical’s ColoTest has a suggested retail price of $19.99 and will also be sold on major retail shelves later this spring.

201
201
article thumbnail

Cholera vaccine shortage reaches worst point yet, with experts fearing deadly outbreaks

STAT

An unprecedented shortage of cholera vaccine has public health experts fearing that a recent surge of outbreaks across developing countries will only worsen, a situation they argue is as regrettable as it was avoidable. At least 16 countries in Asia, Africa, and the Caribbean are dealing with cholera outbreaks. According to the latest report from the European Centre for Disease Prevention and Control , between Dec. 23 and Jan. 23, nearly 50,500 people contracted cholera and nearly 500 died.

Vaccines 145
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Know Labs Announces Wearable, Non-Invasive Continuous Glucose Monitor

Drug Topics

If approved, KnowU will become the world’s first non-invasive blood glucose monitor introduced to the global marketplace.

194
194
article thumbnail

STAT+: FTC says pharmacy benefit managers are stonewalling requests for information

STAT

A much-anticipated inquiry by U.S. antitrust regulators into pharmaceutical industry middlemen has been stymied because the companies have failed to provide many of the documents that, in some cases, were requested as far back as June 2022. The inquiry was begun by the Federal Trade Commission in response to the role that pharmacy benefit managers play in the cost of prescription medicines.

article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

ViVE 2024: Veradigm buys ScienceIO in $140M deal to build out healthcare AI solutions

Fierce Healthcare

LOS ANGELES — Healthcare data and tech company Veradigm is picking up ScienceIO in a $140 million deal to build out large language models for healthcare. | Veradigm plans to use the company's platform to create its own proprietary large language models on its own massive dataset, which includes 400,000 providers and over 200 million patients.

130
130
article thumbnail

Opinion: IVF bans like Alabama’s could cost the lives of children already born

STAT

When my wife, Laurie, completed her ninth in vitro fertilization cycle in the spring of 2000, we had more than 150 fertilized embryos in frozen storage at the Center for Reproductive Medicine and Infertility at the NewYork Presbyterian Hospital-Weill Medical College of Cornell University. We were not stockpiling them for later use. At the time, our son Henry was 5.

Hospitals 136

More Trending

article thumbnail

Protocols originally intended to be extra conservative are now heralded as evidence of mifepristone’s risk

STAT

Decisions made by the Food and Drug Administration more than 20 years ago have come under heightened scrutiny thanks to a lawsuit calling for increased restrictions around the pregnancy-terminating drug mifepristone. The Alliance of Hippocratic Medicine, a recently formed umbrella organization composed of several anti-abortion groups, has argued the protocols first adopted to safeguard mifepristone are indicative of the drug’s danger.

article thumbnail

Industry Pharmacists Organization (IPhO) Releases a New Report Summarizing the Current State of Pharmacist Job Satisfaction

Drug Topics

Survey data from nationally conducted studies of pharmacist practice settings including community, health system, and clinical pharmacy are consistently showing between 40-60% reporting job dissatisfaction and/or burnout

98
article thumbnail

STAT+: Viking Therapeutics obesity drug hits target in key study, raising hopes for a competitor to existing medicines

STAT

An obesity medication from Viking Therapeutics succeeded in a Phase 2 clinical study, the company said Tuesday, helping patients lose up to nearly 15% of their weight over about three months and further fueling the competition in the exploding obesity drug market.   Shares of the San Diego-based company doubled in premarket trading.   The trial tested four different weekly injectable doses of the Viking drug, called VK2735, over 13 weeks, with patients seeing a dose-dependent amount of

124
124
article thumbnail

Biktarvy Indication Expanded by FDA for Resistant HIV

Drug Topics

The new approval is supported by the phase 3 Study 4030, which evaluated the efficacy, safety, and tolerability profile of Biktarvy in a broad range of people with HIV-1 with or without pre-existing NRTI resistance, including those with the M184V/I resistance.

FDA 98
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

GSK pill works in uncomplicated gonorrhea

STAT

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Hi. Hello. It’s Meghana. Today we’re excited to unveil the 2024  STATUS List , a rundown of the 50 most influential people shaping the future of health and life sciences across biotech, medicine, health care, policy, and health tech.

FDA 124
article thumbnail

Why is pharma going gaga for radiopharmaceuticals?

pharmaphorum

Pharmaceutical companies are increasingly focusing on radiopharmaceuticals due to their potential in oncology and therapeutic applications. Learn more about why the industry is excited about radioisotopes in this article.

article thumbnail

Opinion: Palliative psychiatry offers a new path for some people with serious mental illness

STAT

The Canadian surgeon and urologist Balfour Mount is considered the father of palliative care in North America. He was inspired and mentored by Cicely Saunders, a British nurse and social worker. Before she became a physician, Saunders developed the first modern hospice , St Christopher’s in London in 1967. Mount adapted and transplanted approaches to the care of the terminally ill he had learned at St Christopher’s to the Royal Victoria Hospital in Montreal.

Hospitals 123
article thumbnail

Nearly all doctors suffer burnout, survey finds, but many cautiously hopeful that AI could help

Fierce Healthcare

Nearly all physicians in the U.S. | Nearly all physicians in the U.S. said they feel regularly burned out and over half of them have considered either leaving the profession or adopting non-patient-facing roles, according to a new Athenahealth survey.

120
120
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

AstraZeneca finally drops roxadustat US rights after FDA rejection, trial failure

Fierce Pharma

AstraZeneca and FibroGen have finally reached the end of the road for their U.S. collaboration on the oral anemia drug roxadustat. | More than two years after a high-profile FDA rejection, AstraZeneca has backed out of a collaboration with FibroGen for the latter’s oral anemia drug roxadustat in the U.S. Still, AZ left the partners' China pact intact.

FDA 115
article thumbnail

Accelerating the process, transforming therapies and advancing precision medicine

pharmaphorum

Next-generation technology is enabling drug discovery at an entirely new scale, accelerating the process, transforming therapies and advancing precision medicine, and resulting in better patient outcomes. In this podcast, Dr Mohit Jain, founder and CEO of Sapient, discusses personalised disease prediction, diagnostics, and therapies.

114
114
article thumbnail

Alignment Healthcare to eliminate ACO REACH exposure, exceeds revenue expectations

Fierce Healthcare

Insurtech Alignment Healthcare has recorded $1.82 billion in revenue for full-year 2023 and beat market expectations for quarterly revenue by more than $20 million, the company announced Feb. | Alignment Healthcare stressed it should reach profitability this year and announced it would pulling back from the ACO REACH program, the company said during a fourth-quarter earnings call.

113
113
article thumbnail

Cosnova Beauty sets its sights on growth in 2024

Drug Store News

DSN spoke to Cosnova founder Christina Oster-Daum and Jill Krakowski, chief marketing officer, USA, about the company’s growth, plans for the year ahead and how social media has played a key role in the popularity of its brands.

111
111
article thumbnail

FDA says yes to Allecra, no to Venatorx UTI drugs

pharmaphorum

The FDA has approved Allecra Therapeutics' Exblifep, a combination antibiotic for complicated urinary tract infections (cUTIs) that will now launch later this year, but turned down a rival product from Venatorx.

FDA 108
article thumbnail

PE-backed anesthesiology group ends contracts with 5 Colorado hospitals, phases out non-competes to resolve monopoly inquiry

Fierce Healthcare

PE-backed anesthesiology group ends contracts with 5 Colorado hospitals, phases out non-competes to resolve monopoly inquiry dmuoio Tue, 02/27/2024 - 15:40

Hospitals 112
article thumbnail

iA launches shared central fulfillment solution

Drug Store News

iA’s NEXiA software now enables central fill operations with the ability to monetize excess capacity within a central fulfillment operation while providing operations across multiple pharmacy providers.

105
105
article thumbnail

What are the best blood pressure medications for erectile dysfunction?

The Checkup by Singlecare

You might not know that ED (erectile dysfunction) is associated with other health issues—like high blood pressure (also known as hypertension). In a SingleCare survey , high blood pressure was reported or believed to be the most common physical cause of ED. High blood pressure medications can sometimes alleviate erectile dysfunction by reducing stress on the blood vessels and allowing more normal blood flow.

article thumbnail

Food Lion Feeds partners with CIAA Schools to address food insecurity

Drug Store News

Food Lion Feeds is helping provide nonperishable food to eight Historically Black Colleges and Universities that are part of the Central Intercollegiate Athletic Association.

104
104
article thumbnail

Europe’s commercial leaders prepare for a faster trial-to-treatment pathway

pharmaphorum

Europe's commercial leaders are gearing up for a faster trial-to-treatment pathway, leveraging CRM technology to empower HCPs and sales teams.

112
112
article thumbnail

Kristin Ess’ Softening Collection caters to over processed, dry tresses

Drug Store News

The brand’s new Softening Collection offers four new products that not only wash but hydrate and help style strands that may otherwise be over-processed, dry or dull.

105
105
article thumbnail

Looking to the future of clinical trials: Gene therapy, precision medicine, and the ongoing quest for rare disease solutions

pharmaphorum

Looking to the future of clinical trials: Gene therapy, precision medicine, and the ongoing quest for rare disease solutions Mike.

119
119
article thumbnail

Biogen's Qalsody receives positive opinion from CHMP for ALS treatment in Europe

Outsourcing Pharma

Biogen Inc. has announced a significant advancement in the treatment of amyotrophic lateral sclerosis (ALS), commonly known as motor neuron disease (MND).

105
105
article thumbnail

Study rings warning bell over cancer therapy access in UK

pharmaphorum

UK cancer survival is lagging 10-15 years behind other countries due to lower rates of chemotherapy and radiotherapy, says UCL study backed by CRUK.

article thumbnail

Amgen opens its most advanced manufacturing facility to date

European Pharmaceutical Review

Amgen has opened a new biomanufacturing plant in Central Ohio, US. It is the company ’s most advanced manufacturing facility to date. The new facility, known as Amgen Ohio, “was designed with the latest innovation and technology to deliver safe, reliable medicines for ‘every patient, every time,'” stated Robert Bradway, Chairman and Chief Executive Officer at Amgen. “As part of Amgen’s global biomanufacturing network, Amgen Ohio will play an important role in helping us

article thumbnail

Minerva slumps as FDA finds fault with schizophrenia filing

pharmaphorum

FDA has turned down Minerva Neurosciences' marketing application for roluperidone as a treatment for the negative symptoms of schizophrenia

FDA 109
article thumbnail

Biogen's Qalsody receives positive opinion from CHMP for ALS treatment in Europe

Outsourcing Pharma

Biogen Inc. has announced a significant advancement in the treatment of amyotrophic lateral sclerosis (ALS), commonly known as motor neuron disease (MND).

103
103
article thumbnail

UK biotech Curve swings £40.5m in Pfizer-backed round

pharmaphorum

UK biotech Curve Therapeutics raises $51 million in a Pfizer-led Series A that will support its platform for screening drugs within cells.

112
112
article thumbnail

Briogeo launches at Cosmo Prof locations

Drug Store News

Through this partnership, Briogeo plans to connect with more stylists in the Cosmo Prof network by rolling out salon-specific education programs.

104
104
article thumbnail

ViVE 2024: Optum Health CEO talks cyberattack, what's next for value-based care

Fierce Healthcare

LOS ANGELES — Optum Health CEO Amar Desai took the stage at ViVE on Monday morning to discuss the company's value-based care ambitions and strategy, but there was a clear elephant in the room: | LOS ANGELES — Optum Health CEO Amar Desai took the stage at ViVE on Monday morning to discuss the company's value-based care ambitions and strategy, but there was a clear elephant in the room: the cyberattack on Change Healthcare that's still causing disruption nationwide.

98